Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MU vs GSK✓SelectedUSD · GSKMU vs GSK performance historyLatest closeAs of-2.10%11/19
Stock and ETF performance explorer

MU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+3,533.4%
GSK return
+97.7%
Excess return
+3,435.8%
Maximum drawdown
-57.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-1.6%-0.5%-1.7%
7D-13.5%-4.7%-8.8%-12.4%
30D-22.9%-4.7%-18.2%-22.1%
3M-26.3%-8.8%-17.6%-24.7%
6M-1.2%-4.6%+3.5%-1.4%
YTD+142.1%+1.0%+141.1%+134.2%
1Y+206.0%+6.9%+199.1%+189.5%
3Y+798.8%+52.5%+746.3%+606.1%
5Y+751.7%+40.3%+711.4%+580.7%
All+3,533.4%+97.7%+3,435.8%+2,358.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling